Software Solutions

Software Solutions

The systems that carry your compliance

Selection, implementation and validation of the digital systems that run a compliant life-sciences operation — chosen for the scale you actually are, and validated in proportion to the risk they actually carry.


Five systems, one compliance chain

Most regulatory findings that look like software problems are really governance problems: an audit trail nobody reviews, a supplier nobody audited, a training record nobody can produce. We select and validate systems so the evidence exists before an inspector asks for it.

Regulatory

RIM and eCTD publishing

  • Regulatory Information Management selection and implementation
  • eCTD publishing, validation and lifecycle management
  • Submission archives and dossier reuse across markets
  • eCTD v4.0 readiness planning

Quality

Electronic QMS

  • eQMS selection, configuration and document control
  • Deviations, CAPA, change control and effectiveness checks
  • Supplier and distributor qualification records
  • Periodic review and audit-trail review workflows

Safety

Pharmacovigilance databases

  • Safety database selection and configuration
  • EudraVigilance connectivity — gateway or EVWEB
  • ICH E2B(R3) compliance and XCOMP test-environment qualification
  • Signal management and literature screening workflows

Training

Learning management

  • LMS selection and GxP curriculum design
  • Role-based training matrices tied to job descriptions
  • Effectiveness assessment and retraining triggers
  • Inspection-ready training records on demand

Validation

Computer system validation

  • Risk-based CSV to GAMP 5 Second Edition
  • EU GMP Annex 11 and 21 CFR Part 11 compliance
  • URS, supplier assessment, IQ/OQ/PQ and traceability
  • Periodic review, data migration and decommissioning

Data

Data integrity and master data

  • ALCOA+ gap assessments across GxP systems
  • Audit-trail design and risk-based review procedures
  • Identity and access management, segregation of duties
  • Article 57 / XEVMPD product data maintenance

The rules these systems answer to

A short, current map of what applies — and what is still in draft. We track the difference, because validating against a guideline that has not been adopted wastes money, and ignoring one that has costs more.

InstrumentStatusWhat it governs
EU GMP Annex 11Revision of January 2011 remains in forceComputerised systems in GMP. A draft revision and a new draft Annex 22 on artificial intelligence were consulted on from 7 July to 7 October 2025; neither had been adopted as of autumn 2026, and no application date has been announced.
EudraLex Vol. 4 Chapter 4January 2011 version in forceDocumentation. Under revision in the same consultation package.
GAMP 5, Second EditionISPE, July 2022Industry guidance, not law. Software categories 1, 3, 4 and 5; critical thinking; cloud and SaaS; agile and iterative development; AI/ML.
21 CFR Part 11In forceFDA electronic records and electronic signatures. FDA’s Computer Software Assurance guidance was finalised in September 2025 and superseded by a retitled final guidance in February 2026; it is device-framed but its risk-based principles are widely applied.
PIC/S PI 041-1In force since 1 July 2021Data management and integrity in regulated GMP/GDP environments.
MHRA GXP Data Integrity GuidanceRevision 1, March 2018Data integrity across GLP, GCP, GMP, GDP and GPvP.
EMA guideline on computerised systems in clinical trialsApplied from September 2023Electronic data in clinical trials. Note it uses ALCOA++, adding traceable.
EudraVigilance / ICH E2B(R3)Mandatory since 30 June 2022ICSR reporting format. Gateway submitters require XCOMP testing.
eCTDMandatory in all EU procedureseCTD v3.2.2 with EU Module 1 v3.1.1 has been the baseline since 1 December 2025. Optional use of eCTD v4.0 for new centralised applications opened in December 2025. Under EMA’s roadmap, v4.0 becomes the strongly recommended format for new centralised applications from Q1 2027 and mandatory for new centralised applications from Q1 2028; dates for existing v3.2.2 lifecycles and for DCP, MRP and national procedures have not yet been announced. In the US, FDA has accepted v4.0 submissions to applications established in v3.2.2 since 16 October 2026, with no mandatory date.
EU AI Act (Regulation (EU) 2024/1689)PhasedAI literacy obligations have applied since 2 February 2025 and general application began 2 August 2026. Regulation (EU) 2026/1744 deferred Annex III high-risk obligations to 2 December 2027; Annex I product-embedded systems follow on 2 August 2028.
Two things worth knowing before you budget. There is no published cutover date for moving Article 57 product data from XEVMPD to an IDMP-compliant format — EMA says only that it will change “in due course”, so treat any vendor deadline with scepticism. And neither EU GMP Chapter 2 nor the GDP Guidelines set a retention period for training records; the common “five years” is convention, not a codified rule.

How we run a validation

Risk-based, least-burdensome, and sized to the system. A configured off-the-shelf eQMS should not be validated as though it were custom code.

Intended use

Define what the system does, which GxP records it holds and which decisions depend on it.

Risk assessment

Categorise the software, assess process risk and set the assurance effort accordingly.

Supplier assessment

Audit or assess the vendor or service provider, and secure audit rights, SLAs and an exit route for your data.

Specification and testing

URS through to scripted, unscripted or hybrid testing in proportion to risk, with traceability throughout.

Release and record

Validation report, training, and the documented evidence an inspector will ask to see.

Periodic review

Audit trails, access reviews, security incidents, restore tests and change control — through to decommissioning.

Our platforms

Alongside our consulting and system validation work, four platforms serve the day-to-day information, training and validation needs of regulatory, pharmacovigilance and quality teams.

Validation & compliance monitoring

VigiRadar

A computerised system validation platform for GxP teams, built for risk-based assurance under FDA Computer Software Assurance, GAMP 5, EU GMP Annex 11, 21 CFR Part 11 and the draft Annex 22 on AI, from intended use to decommissioning.

  • Supplier release triage: vendor release notes mapped to your requirements, with GxP impact and a proposed regression set
  • Annex 11 and Part 11 control matrix with evidence references and gap heatmaps
  • Annex 22 eligibility check for embedded AI models
  • Per-system inspection-readiness scores, risk heatmaps and review calendars
  • Hash-chained audit trail and record-bound e-signatures, with EU hosting

Visit VigiRadar →

Regulatory intelligence

VigiEye

A daily news service on the regulatory and safety side of medicines, so teams see developments as they happen.

  • PRAC safety signals and recommendations
  • EMA and FDA guidance updates
  • Product recalls and safety communications
  • PDUFA dates and EU approvals

Visit VigiEye →

Industry news

CompePharma

A business news platform covering the commercial side of the pharmaceutical industry, drawing on official FDA, EMA and European Commission records and regulatory filings.

  • Deals, M&A and financing
  • Approvals and launches
  • Manufacturing, supply, pricing and policy
  • Earnings, pipeline and R&D analysis

Visit CompePharma →

Training

Competrain

An online training provider for business and life-science operations, with pay-per-course access and certificates of completion rather than a subscription.

  • Courses covering quality, compliance, data, finance and leadership
  • AI SOP trainer that turns a procedure into a module with quizzes and sign-off
  • Custom courses built from your own documents
  • Corporate LMS with role-based assignment and audit trail

Visit Competrain →

Choosing a system, or validating one you already have?

Tell us what you run today and what you are being asked to prove. We will tell you what genuinely needs validating, and what does not.

Book a Consultation